This application for continuation of the Specialized Program of Research Excellence (SPORE) in Head and Neck Cancer at The Johns Hopkins University School of Medicine supports a highly interactive, multidisciplinary, and interinstitutional program. Five research projects, three cores, a career development and a research developmental program are proposed to carry out our translational research in head and neck cancer. Research Project #1 - Molecular Screening and Risk Prediction of HNSC. - Co- Investigators, William Westra (basic) and Wayne Koch (clinic). Research Project #2 - Tumor Suppressor Gene Promoter Hypermethylation for Detection of Head and Neck Cancer - Co-Investigators, David Sidransky (basic) and Joseph Califano (clinic). Research Project #3 - HPV Vaccine Therapy and Correlates of Response in Head and Neck Squamous Cell Carcinomas (HNSC) - Co-investigators, TC Wu & Keerti Shah (basic) and Maura Gillison (clinic). Research Project #4 - Combined Modalidty Treatment of Head and Neck Cancer Evaluating Inhibitors of the EGFR/TK Pathway - Co-Investigators, Edward Ratovitski & Manuel Hidalgo (basic) and Arlene Forastiere (clinic). Research Project #5 - Exploitation of RET Inhibitors for Treatment of Thyroid Cancer - Co-Investigators, Barry Nelkin (basic) and Doug Ball (clinic). The cores support the research programs (Core #1 - Pathology/Tissue Core, Dr. Westra; and Core #2 - Administrative/Clinical Core (Drs. Sidransky & Forastiere), Core #3 - Biostatistics and Bioinformatics Core (Dr. Goodman). The Career Development Program (Dr.Forastiere) aids the emergence of new investigators and the Research Developmental Program (Dr. David Sidransky) provides rapid funding of innovative directions.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
1P50CA096784-01
Application #
6513625
Study Section
Special Emphasis Panel (ZCA1-SRRB-E (M1))
Program Officer
Ujhazy, Peter
Project Start
2002-09-12
Project End
2007-05-31
Budget Start
2002-09-12
Budget End
2003-05-31
Support Year
1
Fiscal Year
2002
Total Cost
$1,888,925
Indirect Cost
Name
Johns Hopkins University
Department
Otolaryngology
Type
Schools of Medicine
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Mao, Chih-Ping; Peng, Shiwen; Yang, Andrew et al. (2018) Programmed self-assembly of peptide-major histocompatibility complex for antigen-specific immune modulation. Proc Natl Acad Sci U S A 115:E4032-E4040
Bishop, Justin A; Andreasen, Simon; Hang, Jen-Fan et al. (2017) HPV-related Multiphenotypic Sinonasal Carcinoma: An Expanded Series of 49 Cases of the Tumor Formerly Known as HPV-related Carcinoma With Adenoid Cystic Carcinoma-like Features. Am J Surg Pathol 41:1690-1701
Guo, Theresa; Sakai, Akihiro; Afsari, Bahman et al. (2017) A Novel Functional Splice Variant of AKT3 Defined by Analysis of Alternative Splice Expression in HPV-Positive Oropharyngeal Cancers. Cancer Res 77:5248-5258
Fakhry, Carole; Qualliotine, Jesse R; Zhang, Zhe et al. (2016) Serum Antibodies to HPV16 Early Proteins Warrant Investigation as Potential Biomarkers for Risk Stratification and Recurrence of HPV-Associated Oropharyngeal Cancer. Cancer Prev Res (Phila) 9:135-41
Patel, Mira A; Blackford, Amanda L; Rettig, Eleni M et al. (2016) Rising population of survivors of oral squamous cell cancer in the United States. Cancer 122:1380-7
Mydlarz, Wojciech K; Hennessey, Patrick T; Wang, Hao et al. (2016) Serum biomarkers for detection of head and neck squamous cell carcinoma. Head Neck 38:9-14
Ferguson, Lynnette R; Chen, Helen; Collins, Andrew R et al. (2015) Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition. Semin Cancer Biol 35 Suppl:S5-S24
Califano, Joseph A; Khan, Zubair; Noonan, Kimberly A et al. (2015) Tadalafil augments tumor specific immunity in patients with head and neck squamous cell carcinoma. Clin Cancer Res 21:30-8
Gaykalova, Daria A; Vatapalli, Rajita; Wei, Yingying et al. (2015) Outlier Analysis Defines Zinc Finger Gene Family DNA Methylation in Tumors and Saliva of Head and Neck Cancer Patients. PLoS One 10:e0142148
Lee, Young-Ho; Bae, Hyun Cheol; Noh, Kyung Hee et al. (2015) Gain of HIF-1? under normoxia in cancer mediates immune adaptation through the AKT/ERK and VEGFA axes. Clin Cancer Res 21:1438-46

Showing the most recent 10 out of 107 publications